ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,358 | -0.0% | 21,475 | -12.6% | 0.00% | – |
| Q2 2023 | $66,374 | -64.8% | 24,583 | -61.2% | 0.00% | – |
| Q1 2023 | $188,298 | +13.9% | 63,400 | -3.4% | 0.00% | – |
| Q4 2022 | $165,312 | +132.8% | 65,600 | +68.2% | 0.00% | – |
| Q3 2022 | $71,000 | +31.5% | 39,000 | +128.1% | 0.00% | – |
| Q2 2022 | $54,000 | -59.4% | 17,100 | -20.8% | 0.00% | – |
| Q1 2022 | $133,000 | -98.1% | 21,600 | -95.6% | 0.00% | -100.0% |
| Q4 2021 | $7,034,000 | +28.2% | 495,297 | -27.7% | 0.00% | 0.0% |
| Q3 2021 | $5,485,000 | -73.4% | 685,531 | -4.9% | 0.00% | -80.0% |
| Q2 2021 | $20,590,000 | +45.6% | 720,701 | +48.1% | 0.01% | +66.7% |
| Q1 2021 | $14,137,000 | +195.1% | 486,659 | +21.2% | 0.00% | +200.0% |
| Q4 2020 | $4,791,000 | +72.6% | 401,612 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $2,776,000 | – | 402,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |